Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors

被引：7
|
作者：
Rodriguez-Merchan, E. C.
Valentino, L.
Quintana, M.
机构：
[1] La Paz Univ Hosp, Dept Orthopaed, Madrid, Spain
[2] La Paz Univ Hosp, Haemophilia Unit, Madrid, Spain
[3] Rush Presbyterian St Lukes Med Ctr, Dept Haematol, Chicago, IL 60612 USA
[4] La Paz Univ Hosp, Dept Haematol, Madrid, Spain
来源：
HAEMOPHILIA | 2007年 / 13卷
关键词：
haemophilia; inhibitors; prophylaxis; radiactive synoviorthesis; synovitis;
D O I：
10.1111/j.1365-2516.2007.01540.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prophylaxis is paramount to try to avoid the development of haemophilic synovitis. The best treatment for synovitis in patients with inhibitors is radioactive synoviorthesis (rhenium for ankle and elbows, yttrium for knees). With both methods (prohylaxis and radioactive synoviorthesis), we can delay the development of severe haemophilic arthropathy, that eventually will require major orthopaedic surgery.
引用
收藏
页码：45 / 48
页数：4
相关论文
共 50 条
  • [1] Prophylaxis in haemophilia patients with inhibitors
    Leissinger, C. A.
    HAEMOPHILIA, 2006, 12 : 67 - 72
  • [2] Platelet Rich Plasma for Chronic Synovitis Treatment in Patients with Haemophilia
    Caviglia, H.
    Landro, M. E.
    Daffunchio, C.
    Galatro, G.
    Douglas Price, A. L.
    Salgado, P.
    Neme, D.
    HAEMOPHILIA, 2017, 23 (04) : 613 - 619
  • [3] FEIBA prophylaxis for patients with haemophilia and inhibitors
    Valentino, L. A.
    HAEMOPHILIA, 2006, 12 : 26 - 31
  • [4] Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres
    Di Minno, Matteo Nicola Dario
    Napolitano, Mariasanta
    Giuffrida, Anna Chiara
    Baldacci, Erminia
    Carulli, Christian
    Boccalandro, Elena
    Bruno, Clarissa
    Forneris, Eleonora
    Ricca, Irene
    Passeri, Walter
    Martinelli, Marco
    Rivolta, Gianna Franca
    Solimeno, Luigi Piero
    Martinoli, Carlo
    Rocino, Angiola
    Pasta, Gianluigi
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : 871 - 883
  • [5] Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors
    Fernanda Lopez-Fernandez, Maria
    Altisent Roca, Carmen
    Teresa Alvarez-Roman, Maria
    Canaro Hirnyk, Mariana Isabel
    Eva Mingot-Castellanos, Maria
    Jimenez-Yuste, Victor
    Cid Haro, Ana Rosa
    Perez-Garrido, Rosario
    Sedano Balbas, Carmen
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (05) : 872 - 895
  • [6] Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors
    Valentino, L. A.
    HAEMOPHILIA, 2010, 16 (02) : 263 - 271
  • [7] Rehabilitation of synovitis in patients with haemophilia
    Seuser, A.
    Berdel, P.
    Oldenburg, J.
    HAEMOPHILIA, 2007, 13 : 26 - 31
  • [8] FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
    Perry, D.
    Berntorp, E.
    Tait, C.
    Dolan, G.
    Holme, P. A.
    Laffan, M.
    Lassila, R.
    Mumford, A.
    Pasi, J.
    Wilde, J.
    Will, A.
    Yee, T. T.
    HAEMOPHILIA, 2010, 16 (01) : 80 - 89
  • [9] Inhibitors and prophylaxis in paediatric haemophilia patients: Focus on the German experience
    Kurnik, Karin
    Auerswald, Guenter
    Kreuz, Wolfhart
    THROMBOSIS RESEARCH, 2014, 134 : S27 - S32
  • [10] Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    HAEMOPHILIA, 2020, 26 (01) : 41 - 46
12345